Correlation Between UMWELTBANK and Diamyd Medical

Can any of the company-specific risk be diversified away by investing in both UMWELTBANK and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UMWELTBANK and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UMWELTBANK and Diamyd Medical AB, you can compare the effects of market volatilities on UMWELTBANK and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UMWELTBANK with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of UMWELTBANK and Diamyd Medical.

Diversification Opportunities for UMWELTBANK and Diamyd Medical

0.73

Correlation Coefficient

UMWELTBANK  Diamyd Medical

Poor diversification

The 3 months correlation between UMWELTBANK and Diamyd is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding UMWELTBANK and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and UMWELTBANK is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UMWELTBANK are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of UMWELTBANK i.e., UMWELTBANK and Diamyd Medical go up and down completely randomly.

Pair Corralation between UMWELTBANK and Diamyd Medical

Assuming the 90 days trading horizon UMWELTBANK is expected to generate 0.29 times more return on investment than Diamyd Medical. However, UMWELTBANK is 3.46 times less risky than Diamyd Medical. It trades about -0.17 of its potential returns per unit of risk. Diamyd Medical AB is currently generating about -0.14 per unit of risk. If you would invest  604.00  in UMWELTBANK on December 22, 2024 and sell it today you would lose (98.00) from holding UMWELTBANK or give up 16.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.36%
Values	Daily Returns

UMWELTBANK  vs.  Diamyd Medical AB

UMWELTBANK

Risk-Adjusted Performance

Very Weak

Over the last 90 days UMWELTBANK has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's forward-looking signals remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Diamyd Medical AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with UMWELTBANK and Diamyd Medical

The main advantage of trading using opposite UMWELTBANK and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UMWELTBANK position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.

The idea behind UMWELTBANK and Diamyd Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..